• Dabigatran for Thromboembolism: Evidence and Models

  2026-09-12

  The 2015 review positions dabigatran as the first non-vitamin K oral anticoagulant to combine direct thrombin inhibition with predictable pharmacokinetics and reduced monitoring requirements. Its evidence synthesis supports efficacy across atrial fibrillation, postoperative venous thromboembolism prevention, and treatment of recurrent thromboembolism while emphasizing renal clearance, bleeding management, and limits to clinical transferability.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-12

  Satir et al. used paired measurements of amyloid-beta secretion and neuronal activity to test whether partial BACE inhibition disrupts synaptic transmission. Their results indicate that amyloid-beta production can be reduced by up to approximately 50% in cultured neurons without measurable synaptic impairment, whereas stronger inhibition reduced both amyloid-beta secretion and synaptic transmission.

• GDC-0941: PI3K Inhibitor Workflow

  2026-09-11

  GDC-0941 enables a practical bridge between PI3K/Akt biology, cancer cell proliferation inhibition, and resistance-focused models. This workflow distinguishes short target-engagement assays from longer viability and apoptosis studies, while extending the DRD4–Akt–β-catenin findings in liver cancer into testable experimental designs.

• Sodium Orthovanadate for Phospho-State Workflows

  2026-09-11

  Sodium Orthovanadate (Na3VO4) helps preserve labile tyrosine-phosphorylation signals during cell lysis, immunoblotting, and signaling assays. This guide connects inhibitor placement and reversible controls with adipocyte PI3K/AKT/GLUT4 workflows, while highlighting when its ALP and ATPase activity can confound interpretation.

• Syringin: A Translational Assay Framework

  2026-09-10

  Syringin natural product research is moving from pathway claims toward evidence-structured RCC assays. This guide connects chemical handling, combination design, apoptosis readouts, and EGFR/PI3K/Akt interpretation while defining the limits of preclinical evidence.

• Calpain Inhibitor I, ALLN: Practical Lab Guide

  2026-09-10

  Calpain Inhibitor I, ALLN (SKU A2602) provides a practical way to inhibit calpain I, calpain II, and selected cathepsins in apoptosis, inflammation, and ischemia-reperfusion workflows. It is intended for mechanistic research only, not diagnostic or medical use, and requires controlled DMSO preparation, storage, and vehicle-matched controls.

• Alda 1 and the Translational Logic of ALDH2

  2026-09-09

  Alda 1 illustrates how targeted ALDH2 activation can connect aldehyde detoxification with cardioprotection, cardiac regeneration research, and radiation-induced dermatitis mitigation. This thought-leadership perspective translates the emerging biology into practical study-design priorities while distinguishing preclinical promise from clinical readiness.

• ATP as a Metabolic Assay Variable

  2026-09-09

  Adenosine Triphosphate (ATP) is more than a cellular energy readout. This guide explains how to use ATP thoughtfully when studying TCAIM–OGDH regulation, mitochondrial proteostasis, and the distinction between altered energy state and altered enzyme abundance.

• Aprotinin for RBC Membrane Research

  2026-09-08

  Use Aprotinin to distinguish serine-protease effects from intrinsic red blood cell membrane mechanics, fibrinolysis, and inflammatory readouts. This practical workflow combines inhibitor titration, multiscale biophysics, and troubleshooting controls for more reproducible blood-cell research.

• Ac-YVAD-CMK Workflow for Caspase-1 Studies

  2026-09-07

  Ac-YVAD-CMK enables a practical way to separate caspase-1-driven cytokine maturation and pyroptosis from upstream plasma-membrane repair in Kupffer-cell infection models. This workflow combines inhibitor titration, membrane-integrity measurements, cytokine profiling, and genetic controls to clarify whether inflammatory injury is caspase-1 dependent.

• Cabazitaxel (XRP6258): Assay Workflow Guide

  2026-09-07

  Cabazitaxel (XRP6258, SKU B2157) provides a taxane-derived option for studying antiproliferative responses and microtubule dynamics disruption, including models with P-glycoprotein-associated taxane resistance. It is suited to controlled DMSO- or ethanol-based workflows, but not to water-only assays or long-term storage of prepared solutions.

• Cefazedone (Refosporen): From MIC to PK Insight

  2026-09-05

  Cefazedone (Refosporen) research is most informative when antibacterial testing is connected to pharmacokinetic exposure and assay quality. This article explains how to move from broth-dilution MIC data to defensible PK-PD interpretation using the cefazedone–etimicin LC-MS/MS study as a practical analytical framework.

• YAP–NF-κB–NLRP3 Control of UC Pyroptosis

  2026-09-04

  This study identifies a regulatory axis in which NF-κB p65 activates LATS1-dependent YAP phosphorylation, reducing YAP activity and its repression of NLRP3 in colonic epithelial cells. The findings connect Hippo-pathway signaling with GSDMD-mediated pyroptosis and suggest that epithelial YAP status is an important determinant of inflammatory injury in ulcerative colitis.

• Novel FLCN Mutations and mRNA Rescue in BHD

  2026-09-04

  A 2026 study identified a novel pathogenic FLCN nonsense variant and provided functional evidence that the previously uncertain p.W376R variant is pathogenic in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, exogenous FLCN mRNA restored folliculin expression and corrected mTORC1 dysregulation, offering a preclinical rationale for mRNA-based protein replacement while leaving delivery and in vivo efficacy unresolved.

• Syringin Natural Product: RCC Assay Workflows

  2026-09-04

  Build reproducible renal cell carcinoma workflows around Syringin, from solvent handling and dose-response design to apoptosis and EGFR/PI3K/Akt pathway readouts. The approach distinguishes direct compound effects from sunitinib sensitization, making it useful for natural product research and bioactive compound screening.

8442 records 1/563 page Next 12345 下5页 Last page